BackCorbus Pharmaceuticals Holdings Overview
Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings Target Price

See Corbus Pharmaceuticals Holdings's analyst price targets ($36) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.08

Average Target Price

$36.25227.2% upside

4 analysts in the last 4 months

High: $44 | Low: $33

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-26H.C. Wainwright$35215.9% upsideOpen
2026-08-13Mizuho SecuritiesGraig Suvannavejh$33197.8% upsideOpen
2026-05-22Mizuho SecuritiesGraig Suvannavejh$44297.1% upsideOpen
2026-05-12JefferiesMaury Raycroft$33197.8% upsideOpen
2025-10-29Mizuho Securities$39252% upsideOpen
2025-10-20Piper Sandler$51360.3% upsideOpen
2025-10-20H.C. Wainwright$40261% upsideOpen
2024-12-02Piper SandlerBiren Amin$35215.9% upsideOpen
2024-10-21OppenheimerJeff Jones$60441.5% upsideOpen
2024-09-20B.Riley FinancialKalpit Patel$40261% upsideOpen
2024-09-13Mizuho SecuritiesGraig Suvannavejh$74567.9% upsideOpen
2024-08-07OppenheimerJeff Jones$88694.2% upsideOpen
2024-07-22H.C. WainwrightAndres Maldonado$80622% upsideOpen
2024-06-11RBC CapitalBrian Abrahams$82640.1% upsideOpen
2024-06-03OppenheimerJeff Jones$80622% upsideOpen
2024-05-20RBC CapitalBrian Abrahams$77594.9% upsideOpen
2024-03-06JefferiesMaury Raycroft$46315.2% upsideOpen

Corbus Pharmaceuticals Holdings (CRBP) FAQ

The latest target price for CRBP is $36. Investors often review this figure alongside Corbus Pharmaceuticals Holdings's historical trend and sector peers before judging valuation or financial health.

Corbus Pharmaceuticals Holdings trades near $11.08 while the consensus target sits at $36 (227.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CRBP's target price ($36), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Corbus Pharmaceuticals Holdings's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.